Arpita Kulshrestha

2PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 16, 2020
In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses.

Arpita Kulshrestha, Gajendra K Katara, Safaa A Ibrahim

|May 07, 2019
Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway.

Arpita Kulshrestha, Gajendra K Katara, Safaa A Ibrahim

Pageof 1

Frequent Collaborators

2 joint publications

Kenneth D Beaman

1 joint publications

Gajendra K Katara